PRODUCT LITERATURE

A Double-Blind, Randomized, Non-Inferiority Study of Efficacy and Safety of OMZ Injection And Originator In the Gastric secretion Control after Pylorus-Preserving Pancreaticoduodenectomy

---

To evaluate the efficacy and safety of adding the once-weekly DPP-4 inhibitor omarigliptin or the sulfonylurea glimepiride to the treatment regimen of patients with type 2 diabetes (T2DM) and inadequate glycemic control on metformin monotherapy

---

Availability

Detail Information

Series Title

-

Call Number

-

Publisher

: .,

Collation

-

Language

English

ISBN/ISSN

-

Classification

NONE

Content Type

-

Media Type

-

Carrier Type

-

Edition

-

Subject(s)

OMZ

Specific Detail Info

Current Medical Research and Opinion, 33:10, 1861-1868

Statement of Responsibility

-

Other version/related

File Attachment

Comments

---

You must be logged in to post a comment